Mab-Venture Forms Ex-China Biosimilar Partnership with BioSciencesCorp

Mab-Venture, a Shanghai biologics company, will collaborate with BioSciencesCorp of San Francisco for ex-China development of several Mab-Venture biosimilars. BioSciencesCorp, together with partners, will conduct clinical trials and commercialize multiple Mab-Venture biosimilars in India , Latin America , Russia/CIS, and other undisclosed territories. Mab-Venture, which has developed and scaled up multiple biosimilars, filed an IND with the CFDA in 2017, and it plans to file several more in 2018. Financial details of the agreement were not disclosed. More details.... Share this with colleagues: // //